ITIH4 and HIV-1 infection: To determine the effect of differential gp120 glycosylation on HIV-1 infection, we tested the ability of gp120 glycoforms generated in different cell types to block SF162 or YU.2 Env-pseudotyped R5 virus infection of TZM-bl reporter cells.